Skip to main content

Table 1 Clinical profiles of the study population

From: Predictive value of pre-procedural autoantibodies against M2-muscarinic acetylcholine receptor for recurrence of atrial fibrillation one year after radiofrequency catheter ablation

Variables

Sinus rhythm (n = 77)

Atrial fibrillation (n = 76)

p value

Age (years)

65.68 ± 9.24

65.34 ± 8.93

0.817

Gender (male)

36 (46.8%)

39 (51.3%)

0.572

Hypertension (%)

36 (36.8%)

37 (48.7%)

0.811

Diabetes mellitus (%)

14 (18.2%)

22 (28.9%)

0.117

Coronary artery disease (%)

8 (10.4%)

9(11.8%)

0.775

Left atrial diameter (mm)

35.33 ± 5.86

39.86 ± 5.35

< 0.001

Left ventricular end-diastolic diameter (mm)

45.34 ± 5.10

46.42 ± 3.92

0.270

Left ventricular end-systolic diameter (mm)

27.55 ± 3.32

28.04 ± 3.26

0.359

Left ventricular ejection fraction (%)

69.13 ± 4.97

69.17 ± 5.98

0.979

NT-proBNP (pg/ml)

113.42 ± 30.15

213.85 ± 85.76

< 0.001

  1. Data were expressed as numbers (%), Mean ± SD.
  2. Abbreviations: NT-proBNP = N-terminal pro-brain natriuretic peptide.